Their limited reliance on cytochrome P450 metabolism reduces the risk of drug-drug interactions, making them suitable for patients on multiple medications [5].​ This diverse array of mechanisms underscores the clinical value of exogenous GLP-1 agonists as an effective and multifaceted therapeutic option for managing T2DM. Here, GLP1R is linked to type 2 diabetes mellitus.